2nd Speech and Swallowing in Parkinson's Disease School
Elina Tripoliti, PhD and Patricia Limousin, MD, PhD
Dysarthria in Parkinson’s disease (PD) is primarily characterized by hypophonia and dysprosody. It worsens during the disease progression with a poor and variable response to pharmacological and/or neurosurgical treatments. Hypophonia in PD usually responds well to intensive speech therapies, but speech therapy is rarely proposed to PD patients. While speech therapy gained growing relevance in the management of patients with PD, evidence-based evaluation of behavioral speech therapies for PD remains difficult due to the heterogeneity of dysarthria, as well as the variety of available treatments. Speech therapy programs are often individually tailored to each patient for reaching specific objectives, therefore limiting the conclusions of clinical trials. Moreover, the need for specific training of therapists may restrict access to this therapy.
The main objective of Speech and Swallowing in Parkinson’s Disease school is to provide an opportunity for speech therapists to keep informed about clinical aspects of Parkinsonism, as well as to provide the most recent knowledge about clinical management of dysarthria in PD. During the school, the idea is to provide recommendations while educating students, clinicians and researchers in order to improve their understanding of speech impairment in PD as a multidimensional, multidisciplinary and multiparametric symptom.
The program is designed as a 1 1/2-days school in order to provide an opportunity for small group workshops. We look forward to an inspiring event, providing a unique opportunity to discuss speech therapy in PD with a transdisciplinary team.
- The participant will be able to discuss the neurological bases of normal speech production and speech impairment in PD and atypical parkinsonism.
- The participant will be able to assess speech impairment and swallowing impairment in PD and its implications on social participation.
- The participant will be able to select and design a rehabilitation program targeting speech and/or swallowing impairments in PD patients.
- The participant will be able to consider technological advances for assessing and treating and monitoring speech and swallowing problems.
- The participant will be able to appreciate the challenge of treating speech impairment as part of a multidisciplinary team.
- The participant will be able to consider patient-reported outcome measures as part of the evaluation and follow-up program of management.
- The participant will be able to identify how and when speech therapy can be fully effective according to disease progression and in association with medical and/or surgical treatments
Speech therapists and speech pathologists; Neurologists and ENTs; Heath professionals specialized in PD management; Speech scientists, and neuroscientists
Wolfson Lecture Theatre
Institute of Neurology
National Hospital for Neurology and Neurosurgery
London, WC1N 3BG
MDS is able to provide participants with a Letter of Support and any course-related documentation needed to assist in obtaining a visa. Please note that MDS is unable to contact the Embassy on your behalf. It is the responsibility of each participant to make the necessary arrangements related to this process. However, if the official handling your application needs further clarification, please have them contact Allie Oakley, Education Coordinator.